After a long 10 months, COVID-19 vaccines are finally here. The next obstacle? Determining how to distribute them efficiently, ethically, and economically. Last week, experts in...
The Context: Neuromuscular disorders such as ALS arise from degeneration of brain cells that send signals to the muscles, and there are no treatments that address...
Watch the Fireside Chat video and read the summary below. After a historic research effort, COVID-19 vaccines are already here. Several of these vaccines, including the...
The Context: Prosthetic implants are regularly used in dentistry and orthopedics, and there are an estimated 2 million Americans living with limb loss today. Most prosthetic...
The Context: Scientists have long known that octopuses are able to taste what they touch with their tentacles, but the way their tentacles sense taste has...
The Context: The choroid plexus is a brain structure that makes cerebrospinal fluid (CSF): liquid that bathes the brain and spinal cord to form a protective...
2020 has been a year like no other. The COVID-19 pandemic has presented the world with unparalleled challenges and has highlighted the need for pioneering biomedical...
We are proud of our scientists and Innovator community who are hard at work developing solutions for those impacted by COVID-19. This ranges from better diagnosing...
Racial and ethnic minorities are disproportionately affected by virtually every major disease of our time, and this gap has only been exacerbated by COVID-19. This year,...
Ezogabine (an epilepsy drug), has successfully reduced a hallmark of ALS in 65 patients participating in a phase 2 clinical trial, according to a recent report...
Cover photo: Dr. Valentina Fossati (NYSCF) and Jason Stein (Aspen Neuroscience) prepare cells for launch. Photo credit: Space Tango Why send cells affected by multiple sclerosis...
The Context: All of our blood cells — including our immune cells — come from a special type of stem cells known as ‘hematopoietic stem cells’...
Drugs that aim to treat Parkinson’s disease (PD) have not fared well in clinical trials, suggesting that there is more to PD than we currently understand....
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
The Context: CRISPR gene editing holds a great deal of promise for correcting disease-causing mutations in humans, potentially as early as during embryonic development. However, before...
The Context: 1 in 3,000 people has a genetic defect called 22q11.2 deletion syndrome, or 22q11DS, putting them at a greater risk for developing schizophrenia. However,...
The Context: Scientists know that the microbes in a mother’s gut can affect brain function in offspring, usually in response to stress, infection, or other adverse...
Top row: Drs. Raffaella Di Micco, Samantha Morris, José Ordovás-Montañés. Bottom row: Drs. Jiami Guo, David Schneider, John Tuthill New York, NY (October 20, 2020) – The...
We are pleased to share that NYSCF Senior Research Investigator Bjarki Johannesson, PhD, and Memorial Sloan Kettering Cancer Center’s Daniela Cornacchia, PhD, have received a Healthy...
The Context: Scientists now understand the symptoms of COVID-19 fairly well, but there are still many unknowns about what happens to cells that are infected by...
At the end of August, 39 high school students who attend different public, private, and charter schools across New York City and the Northeast and hail...
The Context: Organoids – 3D structures of human tissue derived from stem cells – are a critical tool for helping researchers study diseases like cancer and...
The Context: Many drugs cause liver injury in certain patients, and this is a leading cause of acute liver failure in the United States. A major...
